$ cat ./records/gates-foundation-and-wellcome-pledge-300-million-to-cepi-for-futu-2022.txt
Gates Foundation and Wellcome Pledge $300 Million to CEPI for Future Epidemic Preparedness
[RECORD.TXT] · cat --full
The Gates Foundation and Wellcome Trust each pledged $150 million — $300 million combined — to CEPI ahead of a global replenishment conference in March 2022, supporting CEPI's five-year plan to reduce vaccine development time to 100 days for novel pathogens. CEPI had by this point supported 14 COVID-19 vaccine candidates and was advancing next-generation 'variant-proof' and pan-coronavirus vaccine research. The funding helped ensure CEPI's 100 Days Mission — cutting the time from pathogen identification to first vaccine dose — became a formal international target.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation commits $276 million to accelerate malaria eradication amid rising drug and insecticide resistance
Next →
Melinda Gates Confirms Epstein Relationship Contributed to Divorce Decision
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.